Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chison Medical Technologies CoSHSE:688358 -0.40%91 ROC (Joel Greenblatt) % is 58.43% as of Mar. 2026, which is 28% below its 10-year median of 81.30. GuruFocus rates SHSE:688358 with a GF Score™ of 91/100 and a GF Value™ of ¥30.04 (Fairly Valued). The stock has 3 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Chison Medical Technologies Co ranks better than 86.75% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Chison Medical Technologies Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 58.43%.
The historical rank and industry rank for Chison Medical Technologies Co's ROC (Joel Greenblatt) % or its related term are showing as below:
SHSE:688358'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 43.21 Med: 81.3 Max: 229.28
Current: 43.21
During the past 10 years, Chison Medical Technologies Co's highest ROC (Joel Greenblatt) % was 229.28%. The lowest was 43.21%. And the median was 81.30%.
SHSE:688358's ROC (Joel Greenblatt) % is ranked better than 86.75% of 838
companies
in the Medical Devices & Instruments industry
Industry Median: 4.64
vs SHSE:688358: 43.21
Chison Medical Technologies Co (SHSE:688358) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chison Medical Technologies Co ROC (Joel Greenblatt) % Chart
SHSE:688358 vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Chison Medical Technologies Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chison Medical Technologies Co ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chison Medical Technologies Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Chison Medical Technologies Co's ROC (Joel Greenblatt) % falls into.
Chison Medical Technologies Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 58.43% mean?
Chison Medical Technologies Co (SHSE:688358) has a ROC (Joel Greenblatt) % of 58.43% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Chison Medical Technologies Co and its competitors. This is 28% below median its historical median of 81.30. Over the past decade, Chison Medical Technologies Co's ROC (Joel Greenblatt) % has ranged from 43.21 to 229.28. According to the industry distribution chart, Chison Medical Technologies Co ranks #111 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 13.2%.
Is Chison Medical Technologies Co's ROC (Joel Greenblatt) % too high?
Chison Medical Technologies Co's current ROC (Joel Greenblatt) % of 58.43% is 28% below median its 10-year median of 81.30. Over the past 10 years, this metric has ranged from a low of 43.21 to a high of 229.28. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.64. Chison Medical Technologies Co's value of 58.43% is 1159.3% above this industry median. Based on the distribution chart, Chison Medical Technologies Co ranks #111 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Chison Medical Technologies Co has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chison Medical Technologies Co's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Chison Medical Technologies Co ranks #111 out of 838 companies for ROC (Joel Greenblatt) %. This places Chison Medical Technologies Co in the top 13% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 4.64. Chison Medical Technologies Co's value of 58.43% is 1159.3% above this benchmark. Historically, Chison Medical Technologies Co's own ROC (Joel Greenblatt) % has ranged from 43.21 to 229.28 over the past decade. While the company's 10-year median is 81.30 vs. the industry median of 4.64, Chison Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.64, based on 838 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chison Medical Technologies Co's current ROC (Joel Greenblatt) % of 58.43% is 1159.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Chison Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chison Medical Technologies Co's current ROC (Joel Greenblatt) % is 58.43%, which is 28% below median its own 10-year median of 81.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chison Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Chison Medical Technologies Co (SHSE:688358) is currently considered Fairly Valued. The stock's GF Value™ is ¥30.04, compared to a current price of ¥29.70 — trading 1.1% below its estimated fair value. The current ROC (Joel Greenblatt) % is 58.43%, which is 28% below median its 10-year median of 81.30 and 1159.3% above the Medical Devices & Instruments industry median of 4.64. Chison Medical Technologies Co's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Chison Medical Technologies Co (SHSE:688358), the current ROC (Joel Greenblatt) % is 58.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chison Medical Technologies Co (SHSE:688358) Overvalued in 2026?
Based on GuruFocus' analysis, Chison Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥29.70 is trading 1.1% below its estimated GF Value™ of ¥30.04.
GuruFocus considers Chison Medical Technologies Co to be Fairly Valued.
Key valuation signals for SHSE:688358:
ROC (Joel Greenblatt) %: 58.43% (28% below median its 10-year median of 81.30)
GF Value™: ¥30.04 vs. price of ¥29.70 (1.1% below fair value)
Industry Position: 1159.3% above the Medical Devices & Instruments median (#111 of 838)
No single metric tells the full story. See the SHSE:688358 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chison Medical Technologies Co Ltd is a manufacturer and seller of ultrasound medical imaging equipment. The company provides ultrasound diagnostic equipment, health equipment, instrumentation, electronic components, electronic products, electronic equipment, trolleys, general equipment and accessories. Its products include Color Doppler, and B/W system.
91GF Score
Get the complete analysis for SHSE:688358
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688358 has been successfully added to your 
